Related Experiment Video
Updated: Mar 24, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients
Nafees Ahmad1, Arshad Javaid2, Syed Azhar Syed Sulaiman1
1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Abstract:
Although Pakistan has a high burden of multidrug-resistant tuberculosis (MDR-TB), little is known about prevalence, management, and risk factors for adverse drug reactions (ADRs) in MDR-TB patients in Pakistan. To evaluate occurrence, management, and risk factors for ADRs in MDR-TB patients, and its impact on treatment outcomes, this observational cohort study was conducted at programmatic management unit for drug resistant TB of Lady Reading Hospital Peshawar, Pakistan. A total of 181 MDR-TB patients enrolled at the study site from January 1, 2012 to February 28, 2013 were included. Patients with drug resistant TB other than MDR-TB, transferred out patients and those who were still on treatment at the end of study duration (January 31, 2015) were excluded. Patients were followed until treatment outcomes were reported. ADRs were determined by laboratory data and/or clinical criteria. SPSS 16 was used for data analysis. A total of 131 patients (72.4%) experienced at least 1 ADR. Gastrointestinal disturbance was the most commonly observed adverse event (42%), followed by psychiatric disturbance (29.3%), arthralgia (24.3%), and ototoxicity (21%). Potentially life-threatening ADRs, such as nephrotoxicity (2.7%) and hypokalemia (2.8%) were relatively less prevalent. Owing to ADRs, treatment regimen was modified in 20 (11%) patients. On multivariate analysis, the only risk factor for ADRs was baseline body weight ≥ 40 kg (OR = 2.321, P-value = 0.013). ADRs neither led to permanent discontinuation of treatment nor adversely affected treatment outcomes. Adverse effects were prevalent in current cohort, but caused minimal modification of treatment regimen, and did not negatively impact treatment outcomes. Patient with baseline body weight ≥ 40 kg should be closely monitored.
Insights
Adverse drug reactions (ADRs) are common in multidrug-resistant tuberculosis (MDR-TB) patients in Pakistan, but rarely impact treatment outcomes. Patients with a baseline body weight of 40 kg or more are at higher risk for ADRs.
Area of Science:
- Infectious Diseases
- Pharmacovigilance
- Clinical Medicine
Background:
- Pakistan faces a significant burden of multidrug-resistant tuberculosis (MDR-TB).
- Limited data exists on the prevalence, management, and risk factors for adverse drug reactions (ADRs) in Pakistani MDR-TB patients.
- Understanding ADRs is crucial for optimizing treatment and patient outcomes.
Purpose of the Study:
- To evaluate the occurrence, management, and risk factors for ADRs in MDR-TB patients in Pakistan.
- To assess the impact of ADRs on treatment outcomes.
- To identify patient characteristics associated with increased ADR risk.
Main Methods:
- An observational cohort study was conducted at a drug-resistant tuberculosis management unit in Peshawar, Pakistan.
- 181 MDR-TB patients were enrolled between January 2012 and February 2013.
- Patients were followed until treatment outcomes were reported, with ADRs identified through clinical and laboratory data.
Main Results:
- A high prevalence of ADRs was observed, with 131 patients (72.4%) experiencing at least one ADR.
- Gastrointestinal disturbances (42%), psychiatric disturbances (29.3%), arthralgia (24.3%), and ototoxicity (21%) were the most common ADRs.
- Baseline body weight ≥ 40 kg was the only identified risk factor for ADRs (OR = 2.321, P = 0.013).
- Potentially life-threatening ADRs like nephrotoxicity (2.7%) and hypokalemia (2.8%) were less common.
- ADRs led to treatment regimen modification in only 11% of patients and did not negatively impact treatment outcomes.
Conclusions:
- ADRs are highly prevalent in Pakistani MDR-TB patients but generally do not lead to permanent treatment discontinuation or adverse outcomes.
- Patients with a baseline body weight of 40 kg or more require closer monitoring for ADRs.
- This study highlights the need for vigilant monitoring and management of ADRs in MDR-TB treatment programs.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Pharmacokinetics: Drug–Drug Interactions
Drug Toxicity: Overview

